Following the shortage resolution, compounding is generally allowed only when a prescribing clinician determines that a patient has a specific medical need that cannot be met by an FDA-approved drug
Together, the team provides one of Edmontons most comprehensive naturopathic and IV therapy programs
Research Highlights Metformin Study Breakthrough A new study revealed that metformin works through the brain, opening new pathways for diabetes treatment innovation
Medical evidence supports a target of 2.7 to 3.7 liters daily for adults, though individual needs vary based on activity level, climate, and body weight
Despite knowing the symptoms, physicians had no effective means to treat the disease and most patients only lived for a year or more after diagnosis
Owing to their effectiveness in reducing body weight, once-daily subcutaneous administration of liraglutide 3.0 mg has been approved, and once-weekly subcutaneous administration of semaglutide 2.4 mg is being investigated in phase III trials, for obesity management